Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ODS Five-Year Strategic Plan Could Lead To New Goals, Priorities

This article was originally published in The Tan Sheet

Executive Summary

The National Institutes of Health Office of Dietary Supplements is requesting input on "both new opportunities and emerging needs for possible incorporation in the programmatic efforts of the office," as it considers its strategic plan for 2004-2009, according to an April 10 Federal Register notice

You may also be interested in...

NIH Office To "Improve Scientific Methodology" Of Supplement Research

One goal of the National Institutes of Health Office of Dietary Supplements over the next three to five years is to "improve scientific methodology as related to the study of dietary supplements," according to the ODS strategic plan, released Sept. 21.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts